Provista Diagnostics

United States
Troy, New Hampshire, United States, 10004

Company profile

Provista Diagnostics company profile

Provista Diagnostics is a Delaware company, develops and commercializes breakthrough, easy-to-administer blood-based diagnostic tests for early oncology-related disease state recognition and detection purposes. The Company's focus is on oncology-related diagnostics where a significantly high, unmet clinical need for such testing products exists. Near-term development and commercialization efforts focus on women's cancers such as breast and ovarian cancer. Provista Diagnostic’s technologies are developed at our CLIA accredited, GLP compliant, 13,610 sq/ft laboratory facility based in Scottsdale, Arizona. Recently, Provista has formed corporate headquarters in New York to take advantage of the sales, marketing, regulatory and financial expertise in the northeast US.

Business identity

Contact email
[email protected]
Phone number
(212)202-3170
Operating status
Closed
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2007-01-01, Year

Headquarters

Postal code
10004
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
7
Total equity funding
$34.5M
Last funding
Series Unknown / $5.1M / 2016-03-19
Last equity funding
Series Unknown / $5.1M
Articles
10
Exited on
2021-04-22

Founders and investors

No public relation records are available.